Tilisolol
(Preusmjereno sa stranice TWVUMMQUXMYOOH-UHFFFAOYSA-N)
| |||
| (IUPAC) ime | |||
|---|---|---|---|
| (RS)-4-[3-(tert-butilamino)-2-hidroksipropoksi]-2-metilizohinolin-1-on | |||
| Klinički podaci | |||
| AHFS/Drugs.com | Internacionalno ime leka | ||
| Identifikatori | |||
| CAS broj | 85136-71-6 62774-96-3 (hidrohlorid) | ||
| ATC kod | nije dodeljen | ||
| PubChem[1][2] | 5474 | ||
| UNII | QUF41MF56G 
| ||
| KEGG[3] | D08598
| ||
| Hemijski podaci | |||
| Formula | C17H24N2O3 | ||
| Mol. masa | 304,38 g/mol | ||
| SMILES | eMolekuli & PubHem | ||
| |||
| Farmakoinformacioni podaci | |||
| Trudnoća | ? | ||
| Pravni status | ℞ Prescription only | ||
| Način primene | Oralno | ||
Tilisolol (Selekal) je beta blokator.[4]
Reference[uredi | uredi kod]
- ↑ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519.
- ↑ Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
- ↑ Joanne Wixon, Douglas Kell (2000). „Website Review: The Kyoto Encyclopedia of Genes and Genomes — KEGG”. Yeast 17 (1): 48–55. DOI:10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H.
- ↑ Hitoshi Sasaki, Yoshiaki Igarashi, Koyo Nishida, Junzo Nakamura (1993-05-31). „Ocular delivery of the β-blocker, tilisolol, through the prodrug approach”. International Journal of Pharmaceutics 93: 49–60.
